Table Of Content

Infectious Agents and Disease 3:328 © 1994 Raven Press, Ltd., New York Infectious Agents and Disease Volume 3, 1994 Author Index Baer GM, 168 Jewell DA, 155 Pereira L, 9 Balwit JM, 302 Joiner K, 163 Pickup DJ, 116 Bichko V, 94 Joklik W, 215 Pollack JR, 85 Bloom ME, 279 Preiser P, 29 Bolen JB, 128 Kanno H, 279 Prince GA, 1 Brunham RC, 218 Kasper DL, 256 Priola SA, 54 Burkhardt AL, 128 Khabbaz RF, 234 Proctor RA, 302 Kieff E, 128 Raymond GJ, 54 Caughey B, 54 Kilby JM, 313 Roizman B, 53, 215 Chapman LE, 234 Kimerling ME, 245 Chesebro B, 54 Saag MS, 313 Clarke DK, 201 Lai MMC, 98 Sandri-Goldin RM, 59 Crawford LM, 324 Lee JH, 128 Sclar DA, 266 Cullen BR, 68 Lemon SM, 38 Shapiro CN, 38 Liao C-L, 98 Spear PG, 53 de la Torre JC, 201 Lin Y-J, 98 Stanfield RL, 155 Domingo E, 201 Longnecker R, 128 Stura EA, 155 Duarte EA, 201 Tartaglione TA, 266 Dunlap NE, 245 Miller CL, 128 Tavis J, 85 Mori S, 279 Taylor J, 94 Elena SF, 201 Moss B, 215 Tschudi C, 181 Moya A, 201 Tzianabos AO, 256 Fields B, 215 Murphy FA, 50 Fine MJ, 266 Murphy PM, 137 Ullu E, 181 Fremont DH, 155 Vesga O, 302 Netter HJ, 94 Galloway DA, 187 Novella IS, 201 Wain-Hobson §S, 201 Ganem D, 85 Weaver SC, 201 Ghiara JB, 155 Onderdonk AB, 256 Williamson DH, 29 Ginsberg HS, 1 O’Neill RE, 77 Wilson IA, 155 Gooding LR, 106 Osborn JE, 194 Wilson RJM, 29 Wolfinbarger JB, 279 Wu T-T, 94 Hinshaw VS, 275 Palese P, 77 Holland JJ, 201 Peeling RW, 218 Zhang X, 98 Infectious Agents and Disease 3:328 © 1994 Raven Press, Ltd., New York Infectious Agents and Disease Volume 3, 1994 Author Index Baer GM, 168 Jewell DA, 155 Pereira L, 9 Balwit JM, 302 Joiner K, 163 Pickup DJ, 116 Bichko V, 94 Joklik W, 215 Pollack JR, 85 Bloom ME, 279 Preiser P, 29 Bolen JB, 128 Kanno H, 279 Prince GA, 1 Brunham RC, 218 Kasper DL, 256 Priola SA, 54 Burkhardt AL, 128 Khabbaz RF, 234 Proctor RA, 302 Kieff E, 128 Raymond GJ, 54 Caughey B, 54 Kilby JM, 313 Roizman B, 53, 215 Chapman LE, 234 Kimerling ME, 245 Chesebro B, 54 Saag MS, 313 Clarke DK, 201 Lai MMC, 98 Sandri-Goldin RM, 59 Crawford LM, 324 Lee JH, 128 Sclar DA, 266 Cullen BR, 68 Lemon SM, 38 Shapiro CN, 38 Liao C-L, 98 Spear PG, 53 de la Torre JC, 201 Lin Y-J, 98 Stanfield RL, 155 Domingo E, 201 Longnecker R, 128 Stura EA, 155 Duarte EA, 201 Tartaglione TA, 266 Dunlap NE, 245 Miller CL, 128 Tavis J, 85 Mori S, 279 Taylor J, 94 Elena SF, 201 Moss B, 215 Tschudi C, 181 Moya A, 201 Tzianabos AO, 256 Fields B, 215 Murphy FA, 50 Fine MJ, 266 Murphy PM, 137 Ullu E, 181 Fremont DH, 155 Vesga O, 302 Netter HJ, 94 Galloway DA, 187 Novella IS, 201 Wain-Hobson §S, 201 Ganem D, 85 Weaver SC, 201 Ghiara JB, 155 Onderdonk AB, 256 Williamson DH, 29 Ginsberg HS, 1 O’Neill RE, 77 Wilson IA, 155 Gooding LR, 106 Osborn JE, 194 Wilson RJM, 29 Wolfinbarger JB, 279 Wu T-T, 94 Hinshaw VS, 275 Palese P, 77 Holland JJ, 201 Peeling RW, 218 Zhang X, 98 Infectious Agents and Disease 3:329-332 © 1994 Raven Press, Ltd., New York Infectious Agents and Disease Volume 3, 1994 Subject Index Abscess formation Children and infants bacterial structure and function, 256 immunization to hepatitis A, 38 Acquired immunodeficiency syndrome (AIDS) Chlamydia trachomatis non-nucleoside reverse transcriptase inhibitors for antigens, in immunity and pathogenesis, 218 HIV infection, 313 Cis-acting signals research and public policies, 194 coronavirus replication, 98 Adenoviruses influenza virus RNA synthesis, 77 molecular basis of pathogenesis, 1 Compliance TNF-mediated cell death and inflammation, 106 medical, in outpatient management of infection, 266 Aleutian mink disease, 279 Coronavirus Antibiotics RNA replication and transcription, 98 medical compliance in outpatient management of in- Creutzfeldt-Jacob disease fection, 266 prion proteins, and scrapie agent, in neuroblastoma Staphylococcus aureus subpopulations, 302 cells, 54 Antibodies Cytokines recognition of viral antigens, 155 Aleutian mink disease, 279 Antigens and molecular basis of adenovirus pathogenesis, 1 Chlamydia trachomatis, in immunity and pathogene- poxviral modifiers, in infection, 116 sis, 218 Cytomegalovirus Apicomplexans glycoprotein B homologues, 9 malaria and plants, 29 Cytotoxicity Apoptosis adenovirus, molecular basis of pathogenesis, 1 poxviral modifiers of cytokine responses to infection, TNF-mediated, by adenoviruses, 106 116 TNF-mediated, by adenoviruses, 106 DNA plastid, malaria and other apicomplexans, 29 Bacteria Dogs structure and function, in abscess formation, 256 rabies infections, 168 Bacteroides fragilis Drug resistance structure and function, in abscess formation, 256 tuberculosis, 245 Bats rabies infections, 168 Book Review Economics, health Medical Microbiology, 50 medical compliance in outpatient management of in- Bunyaviridae fection, 266 hantavirus epidemic, 234 Editorials Current Frontiers in Virology, 53 Destruction of Smallpox Virus Stocks in National Cell death Repositories: A Grave Mistake and a Bad Prece- TNF-mediated, by adenoviruses, 106 dent, 215 Cervical cancer Promoting Laboratory Research during Infectious papillomavirus vaccines, 187 Diseases Fellowship Training or Telling the Chemokine receptors, and molecular mimicry, herpesvi- Truth About Training in Clinical Research, 163 ruses, 137 Education Chemotherapy teaching vs. learning microbiology, 275 photosynthesis, and malaria and other apicomplex- Electron transport ans, 29 Staphylococcus aureus subpopulations, 302 330 SUBJECT INDEX Epidemics glycoprotein B homologues, 9 AIDS, research and public policies, 194 HIV-1, RNA-sequence-mediated regulation, 68 hantavirus, 234 HSV-1 regulatory protein, splicing inhibition, 59 Epidemiology Historical perspective AIDS, research and public policies, 194 rabies, 168 hantavirus epidemic, 234 Human immunodeficiency virus RNA virus quasispecies, 201 AIDS, research and public policies, 194 Epstein-Barr virus non-nucleoside reverse transcriptase inhibitors, 313 glycoprotein B homologues, 9 protein LMP2A, regulation of reactivation, tyrosine kinases in sIg-mediated signal transduction, 128 ICP27 Eukaryotes HSV-1 regulatory protein, splicing inhibition, 59 trypanosomatid protozoa, 181 Immune response Aleutian mink disease, 279 Chlamydia trachomatis antigens, 218 Food and molecular basis of adenovirus pathogenesis, 1 safety program, 324 Immunization Fox against hepatitis A, 38 rabies infections, 168 Infections abscess formation, bacterial structure and function, 256 Gene expression AIDS, research and public policies, 194 adenovirus, molecular basis of pathogenesis, 1 HIV, non-nucleoside reverse transcriptase inhibitors, HSV-1 regulatory protein, splicing inhibition, 59 313 RNA-sequence-mediated regulation, in HIV-1, 68 medical compliance in outpatient management, 266 RNA virus quasispecies, 201 parvovirus, Aleutian mink disease, 279 Genital tract poxviral modifiers of cytokine responses, 116 papillomavirus vaccines, 187 Staphylococcus aureus variant subpopulations, 302 Genome replication Infectivity coronavirus, 98 and glycoprotein B homologues, in herpesviruses, 9 hepatitis B virus reverse transcription, 85 Inflammation hepatitis delta virus, 94 chemokine receptors, and molecular mimicry by RNA virus quasispecies, 201 herpesviruses, 137 Glycoprotein B TNF-mediated, by adenoviruses, 106 homologues, of herpesviruses, 9 Influenza virus Glycoproteins RNA synthesis, role of cis- and trans-acting factors, adenovirus, molecular basis of pathogenesis, 1 77 Guidelines Interferon health care workers, and drug-resistant tuberculosis, poxviral modifiers, responses to infection, 116 245 Interleukin-1 poxviral modifiers, responses to infection, 116 Interleukin-6 Hantavirus Aleutian mink disease, 279 epidemiology and etiology, 234 Health care workers and drug-resistant tuberculosis, 245 Major histocompatibility complex Heat shock protein immune recognition of viral antigens, 155 Chlamydia trachomatis antigens, 218 Malaria Hepadnavirus and other apicomplexans, 29 genomic replication, hepatitis B virus reverse tran- Microbiology scriptase, 85 food safety program, 324 Hepatitis A teaching vs. learning, 275 immunization to, 38 Monitoring Hepatitis B medical compliance in outpatient management of in- delta virus, pathogenesis and replication, 94 fection, 266 virus, reverse transcriptase, in hepadnaviral genomic replication, 85 Herpesvirus Neoplasms chemokine receptors, 137 cervical cancer, papillomavirus vaccines, 187 Epstein-Barr virus protein LMP2A, regulation of re- Nucleoprotein activation, tyrosine kinases in slg-mediated sig- cis- and trans-acting factors in RNA synthesis, of in- nal transduction, 128 fluenza virus, 77 Infectious Agents and Disease, Vol. 3, No. 6, 1994 SUBJECT INDEX Papillomavirus Signal transduction vaccines, 187 chemokine receptors, and molecular mimicry by Phylogenetics herpesviruses, 137 RNA virus quasispecies, 201 slg-mediated, Epstein-Barr virus protein LMP2A, Plants regulation of reactivation, 128 and malaria and other apicomplexans, 29 Skunks Polyadenylation rabies infections, 168 cis- and trans-acting factors in RNA synthesis, of in- Small colony variants fluenza virus, 77 Staphylococcus aureus subpopulations, 302 HSV-1 regulatory protein, splicing inhibition, 59 Splicing trypanosomatid protozoa, 181 host cell, and HSV-1 regulatory protein, 59 Polysaccharides Spongiform encephalopathy bacterial structure and function, in abscess formation, prion proteins, and scrapie agent, in neuroblastoma 256 cells, 54 Poxviral modifiers Staphylococcus aureus cytokine responses to infection, 116 variant subpopulations, 302 Prion protein Syncytium and scrapie agent, in neuroblastoma cells, 54 herpesvirus, glycoprotein B homologues, 9 Process control microbiological food safety program, 324 Proteins HSV-1 regulatory, splicing inhibition, 59 T lymphocytes prion, and scrapie agent, in neuroblastoma cells, 54 immune recognition of viral antigens, 155 Protozoa, trypanosomatid Tat eukaryotic biology, 181 gene regulation in HIV-1, 68 Pseudorabies virus Tissue culture glycoprotein B homologues, 9 neuroblastoma N2a cells, prion protein and scrapie Public health issues agent, 54 AIDS, research and public policies, 194 Trans-acting signals medical compliance in outpatient management of in- influenza virus RNA synthesis, 77 fection, 266 trypanosomatid protozoa, 181 Transcription cis- and trans-acting factors in RNA synthesis, of in- Rabies fluenza virus, 77 historical perspective, 168 trypanosomatid protozoa, 181 Raccoon Transfection rabies infections, 168 HSV-1 regulatory protein, splicing inhibition, 59 Receptors Trypanosomatid protozoa chemokines, and molecular mimicry, herpesviruses, eukaryotic biology, 181 137 Tuberculosis Respiratory disease drug resistance, 245 hantavirus pulmonary syndrome, 234 Tumor necrosis factor Reverse transcriptase adenovirus, molecular basis of pathogenesis, 1 hepatitis B virus, in hepadnaviral genomic replica- in cell death and inflammation by adenoviruses, 106 tion, 85 Tyrosine kinases non-nucleoside inhibitors, for HIV infection, 313 in slg-mediated signal transduction, Epstein-Barr vi- Risk groups rus protein LMP2A, regulation of reactivation, immunization to hepatitis A, 38 128 RNA encapsidation, hepatitis B virus reverse transcriptase, 85 gene regulation in HIV-1, 68 Vaccines genomic replication, coronavirus, 98 AIDS, research and public policies, 194 genomic replication, hepatitis delta virus, 94 HSV-1 regulatory protein, splicing inhibition, 59 Chlamydia trachomatis antigens, 218 influenza virus, role of cis- and trans-acting factors, immunization to hepatitis A, 38 77 papillomavirus, 187 rabies, 168 trypanosomatid protozoa, 181 RNA virus quasispecies, 201 virus quasispecies, 201 Varicella zoster virus glycoprotein B homologues, 9 Scrapie Virus and prion protein, in neuroblastoma cells, 54 adenovirus, molecular basis of pathogenesis, 1 Infectious Agents and Disease, Vol. 3, No. 6, 1994 332 SUBJECT INDEX adenoviruses, TNF-mediated cell death and inflam- influenza, role of cis- and trans-acting factors in RNA mation, 106 synthesis, 77 Aleutian mink disease, 279 papillomavirus, vaccines, 187 antigens, immune recognition of, 155 poxviral modifiers of cytokine responses to infection, coronavirus, replication and transcription, 98 116 Epstein-Barr virus protein LMP2A, sIg-mediated sig- rabies, historical perspective, 168 nal transduction, 128 RNA quasispecies, 201 hepatitis B, reverse transcriptase, in hepadnaviral genomic replication, 85 hepatitis delta, pathogenesis and replication, 94 herpesvirus, chemokine receptors, 137 Warts herpesviruses, glycoprotein B homologues, 9 papillomavirus vaccines, 187 human immunodeficiency, non-nucleoside reverse Wolf transcriptase inhibitors, 313 rabies infections, 168 Infectious Agents and Disease, Vol. 3, No. 6, 1994